Cargando…
DNase and atelectasis in non-cystic fibrosis pediatric patients
INTRODUCTION: No evidence based treatment is available for atelectasis. We aimed to evaluate the clinical and radiologic changes in pediatric patients who received DNase for persistent atelectasis that could not be attributed to cardiovascular causes, and who were unresponsive to treatment with inha...
Autores principales: | Hendriks, Tom, de Hoog, Matthijs, Lequin, Maarten H, Devos, Annick S, Merkus, Peter JFM |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1269442/ https://www.ncbi.nlm.nih.gov/pubmed/16137347 http://dx.doi.org/10.1186/cc3544 |
Ejemplares similares
-
A successful treatment of a lobar atelectasis in a patient with cystic fibrosis
por: Daccò, Valeria, et al.
Publicado: (2022) -
Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis
por: Pressler, Tacjana
Publicado: (2008) -
How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents
por: Tibosch, Marijke M, et al.
Publicado: (2011) -
Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy
por: Papayannopoulos, Venizelos, et al.
Publicado: (2011) -
Surprise Foreign Body Aspiration with Pistachios in a Patient with Cystic Fibrosis with Persistent Atelectasis on Chest Radiography
por: Arık, Elif, et al.
Publicado: (2022)